Clinical and Experimental Reproductive Medicine

The Korean Society for Reproductive Medicine (대한생식의학회)
권호 표지

Effectiveness of Intravenous Immunoglobulin Therapy in Women with Recurrent Spontaneous Abortions and Elevated Pre-conceptional Peripheral Blood CD56+ Natural Killer Cell Percentage

말초 혈액 CD56+Natural Killer Cell 증가에 기인한 습관성 유산 환자에서 정맥 내 면역글로블린 치료의 효과에 관한 연구

  • Cha, Sun Hwa (Department of Ob/Gyn, Samsung Cheil Hospital, SungKyunkwan University School of Medicine) ;
  • Park, Chan Woo (Department of Ob/Gyn, Samsung Cheil Hospital, SungKyunkwan University School of Medicine) ;
  • Kim, Hae Suk (Department of Ob/Gyn, Samsung Cheil Hospital, SungKyunkwan University School of Medicine) ;
  • Cho, Dong Hee (Department of Laboratory Medicine, Samsung Cheil Hospital, SungKyunkwan University School of Medicine) ;
  • Kim, Jin Young (Department of Ob/Gyn, Samsung Cheil Hospital, SungKyunkwan University School of Medicine) ;
  • Kang, Inn Soo (Department of Ob/Gyn, Samsung Cheil Hospital, SungKyunkwan University School of Medicine) ;
  • Koong, Mi Kyoung (Department of Ob/Gyn, Samsung Cheil Hospital, SungKyunkwan University School of Medicine) ;
  • Yang, Kwang Moon (Department of Ob/Gyn, Samsung Cheil Hospital, SungKyunkwan University School of Medicine)
  • 차선화 (성균관대학교 의과대학 삼성제일병원 산부인과) ;
  • 박찬우 (성균관대학교 의과대학 삼성제일병원 산부인과) ;
  • 김해숙 (성균관대학교 의과대학 삼성제일병원 산부인과) ;
  • 조동희 (성균관대학교 의과대학 삼성제일병원 진단검사의학과) ;
  • 김진영 (성균관대학교 의과대학 삼성제일병원 산부인과) ;
  • 강인수 (성균관대학교 의과대학 삼성제일병원 산부인과) ;
  • 궁미경 (성균관대학교 의과대학 삼성제일병원 산부인과) ;
  • 양광문 (성균관대학교 의과대학 삼성제일병원 산부인과)
  • Published : 2005.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: The aim of present study was to evaluate the effectiveness of low-dose intravenous immunoglobulin (IVIg) therapy in women with recurrent spontaneous abortions (RSA) and elevated pre-conceptional peripheral blood CD56+Natural Killer (NK) cell percentage. Study Design: Retrospective case control study. Materials and Methods: Thirty three women with RSA and elevated pre-conceptional peripheral blood CD56+NK cell percentage who had received low-dose IVIg therapy (400 mg/kg per day, every 4 week, until 20 gestational weeks) were included in this study. Controls were nine women with RSA and elevated pre-conceptional peripheral blood CD56+ Natural Killer (NK) cell percentage who had not received IVIg therapy were included in this study. Medical records of study and control groups were retrospectively analyzed and we compared the successful pregnancy outcomes between two groups. Successful pregnancy outcome was defined as pregnancy ongoing beyond 25 gestational weeks. Results: Age, number of previous abortions, pre-conceptional CD56+NK cell percentage and type of RSA were not statistically different between two groups. Otherwise, twenty-five women who received IVIg therapy (25/33, 75.8%) but, only three women who had not received (3/9, 33.3%) had a successful pregnancy outcome and the rate difference between two groups was statistically significant. Conclusion: Based on our study, low-dose IVIg therapy have a effective role in treatment of RSA patients with elevated pre-conceptional peripheral blood CD56+ Natural Killer (NK) cell percentage, but more larger scaled prospective study is needed for available of conclusive evidence.

Keywords

References

  1. Christiansen OB. A fresh look at the causes and treatments of recurrent miscarriage, especially its immunological aspects. Hum Reprod Update 1996; 2: 271-93 https://doi.org/10.1093/humupd/2.4.271
  2. Christiansen OB, Mathiesen O, Lauritsen JG. Intravenous immunoglobulin treatment of women with multiple miscarriages. Hum Reprod 1994; 7: 718 -22
  3. Daya S. Habitual abortion. Text book of Gynecology. Philadelphia, WE Saunders 1993: 204-30
  4. Daya S. Immunotherapy for unexplained recurrent spontaneous abortion. Infertil Reprod Med Clinics N Am 1997; 8: 65-77
  5. Aoki K, Kajiura S, Matsumoto Y, Ogasawara M, Okada S, Yagarni Y, et al. Preconceptual natural killer cell activity as a predictor of miscarriage. Lancet 1995; 345: 1340-42 https://doi.org/10.1016/S0140-6736(95)92539-2
  6. Kwak JY, Beaman KD, Gilman-Sachs A, Ruiz JE, Schewitz D, Beer AE. Up-regulated expression of CD56+, Cd56+/CD56-, and CD19+ cells in peripheral blood lymphocytes in pregnant women with recurrent pregnancy losses. Am J Reprod Immunol 1995; 34: 93-9 https://doi.org/10.1111/j.1600-0897.1995.tb00924.x
  7. Higuchi K, Aoki K, Kimbara T, Hosoi N, Yamamoto T, Okada H. Suppression of natural killer cell activity by monocytes following immunotherapy for recurrent spontaneous aborters. Am J Reprod lmmunol 1995; 33: 221-7. https://doi.org/10.1111/j.1600-0897.1995.tb00888.x
  8. Emmer PM, Veerhoek M, Nelson WL, Steegers EA, Joosted I. Natural killer cell reactivity and HLA-G in recurrent spontaneous abortion. Transplant Proc 1999; 31: 1838-1840
  9. Ribbing SL, Hoversland RC, Beaman KD. T-cell suppressor factors plays an integral role in preventing fetal rejection. J Reprod lmmunol 1998; 14: 83-95 https://doi.org/10.1016/0165-0378(88)90038-1
  10. Nicols TC, Kang J, Angkachatchai V, Beer AE, Beaman KD. Expression of a membrane form of the pregnancy associated protein TJ6 on lymphocytes. Cell Immunol 1995; 155: 219-29 https://doi.org/10.1006/cimm.1994.1114
  11. Bhat NM, Mithal A, Bieber MM, Herzenberg LA, Teng NNH. Human CD5+ B lymphocytes (B-1 cells) decrease in peripheral blood during pregnancy. J Reprod Immunol 1995; 28: 53-60. https://doi.org/10.1016/0165-0378(94)00907-O
  12. Daya S, Gunby J, Clark DA. Intravenous immunoglobulin therapy for recurrent spontaneous abortion: A meta analysis. Am J Reprod Immunol 1998; 39: 69-76 https://doi.org/10.1111/j.1600-0897.1998.tb00337.x
  13. Ronda N, Hurez V, Kazatchkine MD. Intravenous immunoglobulin therapy of autoimmune and systemic inflammatory disease. Vox Sang 1993; 64: 65 -72 https://doi.org/10.1111/j.1423-0410.1993.tb02521.x
  14. Prasad NK, Papoff G, Zeuner A. Therapeutic preparations of normal poly specific IgG (lVIG) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVlg involving the Fas apoptopic pathway. J Immunol 1998; 161: 3781 -90
  15. Scott JR, Branch W, Kochenour NK, Ward K. In-travenous immunologlobulin treatment of pregnant patients with recurrent pregnancy loss caused by antiphospholipid antibodies and Rh immunization. Am J Obstet Gynecol 1998; 159: 1055-6
  16. Kwak JY, Quilty EA, Gilman-Sachs A, Beaman KD, Beer AE. Intravenous immunoglobulin G infusion therapy in women with recurrent spontaneous abortions of immune etiologies. J Reprod Immunol 1995; 28: 175-88 https://doi.org/10.1016/0165-0378(94)00918-W
  17. Caccavo D, Vaccaro F, Ferri GM, Amoroso A, Bonomo L. Anti-idiotypes against antiphospholipid antibodies are present in normal poly specific immunoglobulins for therapeutic use. J Autoimmun 1994; 7: 537-48 https://doi.org/10.1006/jaut.1994.1039
  18. Tsubakio T, Kurato Y, Katageri S. Alteration of 'l-cell subset and immunoglobulin synthesis in vitro during high dose gammaglobulin therapy in patients with idiopathic thrombocytopenic purpura. Clin Exp Immunol 1983; 53: 697-702
  19. Klaesson S, Ringden O, Markling L, Remberger M, Lundkvist I. Immune modulatory effects of immunologlobulins on cell-mediated immune response in vitro. Scand J Immunol 1993; 38: 477-84 https://doi.org/10.1111/j.1365-3083.1993.tb02591.x
  20. Mannhalter JW, Ahmad R, WolfHM, Eible MM. Effect of polymeric IgG on human monocyte functions. Int Arch Allergy Appl Immunol 1987; 82: 159-67 https://doi.org/10.1159/000234182
  21. Engelhard D, Waner JL, Kapoor N, Good RA. Effect of intravenous immune globulin on natural killer cell activity: Possible association with autoimmune neutropenia and idiopathic thrombocytopenia. J Pediatr 1986; 108: 77-81. https://doi.org/10.1016/S0022-3476(86)80772-7
  22. Coulam CB, Krysa L, Stem J, Bustillo M. Intravenous immunoglobulin for treatment of recurrent pregnancy loss. Am J Reprod Immunol 1995; 34: 333-7(7-12) https://doi.org/10.1111/j.1600-0897.1995.tb00960.x
  23. Daya S, Gunby J, Porter F, Scott J, Clark DA. Critical analysis of intravenous immunoglobulin therapy for recurrent miscarriage. Hum Reprod Update 1999; 5: 475-82 https://doi.org/10.1093/humupd/5.5.475
  24. Yamada H, Morikawa M, Kato EH, Shimada S, Kobashi G, Minakarni H, et al. Preconceptional natural killer cell activity and percentage as predictors of biochemical pregnancy and spontaneous abortion with normal chromosome karyotype. Am J Reprod ImmunoI2003; 50: 351-4 https://doi.org/10.1034/j.1600-0897.2003.00095.x
  25. Dwyer JM. Manipulating the immune system with immune globulin. N Engl J Med 1992; 326: 107-16 https://doi.org/10.1056/NEJM199201093260206
  26. Kwak JY, Kwak FM Ainbinder SW, Ruiz AM, Beer AE. Elevated peripheral blood natural killer cells are effectively suppressed by immunoglobulin G infusion in women with recurrent spontaneous abortions. Am J Reprod Immunol 1996; 35: 363-9 https://doi.org/10.1111/j.1600-0897.1996.tb00495.x
  27. Ruiz JE, K wak JY, Baum L, Gilmansachs A, Beaman KD, Kim YB, et al. Effects of intravenous immunoglobulin G on natural killer cell cytotoxicity in vitro in women with recurrent spontaneous abortion. J Reprod Immunol 1996; 31: 125-41 https://doi.org/10.1016/0165-0378(96)00969-2